Woodcock Requests Independent Review Of Biogen-FDA Aduhelm Interaction … Not Approval Decision

 
• By Sarah Karlin-Smith
  
An OIG investigation would put Biogen and FDA’s relationship under a magnifying glass. • Source: Alamy
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership